End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
9.27
CNY
|
-0.54%
|
|
-4.33%
|
-26.25%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
3,447
|
2,550
|
2,281
|
2,175
|
6,750
|
4,370
|
Enterprise Value (EV)
1 |
3,820
|
3,374
|
3,508
|
3,455
|
6,926
|
4,536
|
P/E ratio
|
30.4
x
|
10.3
x
|
21.7
x
|
-5.83
x
|
75.4
x
|
-101
x
|
Yield
|
0.7%
|
1.97%
|
1.05%
|
-
|
0.38%
|
-
|
Capitalization / Revenue
|
4.1
x
|
1.49
x
|
1.34
x
|
1.76
x
|
5.05
x
|
2.42
x
|
EV / Revenue
|
4.54
x
|
1.97
x
|
2.05
x
|
2.79
x
|
5.18
x
|
2.51
x
|
EV / EBITDA
|
21.2
x
|
7.27
x
|
8.74
x
|
26.9
x
|
27
x
|
18.8
x
|
EV / FCF
|
-10.4
x
|
-14
x
|
-5.28
x
|
67.6
x
|
8.79
x
|
44.3
x
|
FCF Yield
|
-9.65%
|
-7.16%
|
-18.9%
|
1.48%
|
11.4%
|
2.26%
|
Price to Book
|
2.88
x
|
1.79
x
|
1.42
x
|
1.8
x
|
4.15
x
|
2.74
x
|
Nbr of stocks (in thousands)
|
218,322
|
218,322
|
218,322
|
218,346
|
254,061
|
254,061
|
Reference price
2 |
15.79
|
11.68
|
10.45
|
9.960
|
26.57
|
17.20
|
Announcement Date
|
3/30/18
|
3/28/19
|
4/26/20
|
4/26/21
|
3/7/22
|
3/29/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
841.1
|
1,712
|
1,708
|
1,237
|
1,336
|
1,805
|
EBITDA
1 |
180.6
|
463.9
|
401.4
|
128.6
|
256.9
|
241.8
|
EBIT
1 |
150
|
415.8
|
344
|
73.77
|
190.8
|
154.9
|
Operating Margin
|
17.83%
|
24.28%
|
20.14%
|
5.96%
|
14.28%
|
8.58%
|
Earnings before Tax (EBT)
1 |
143.1
|
370.2
|
223.8
|
-389.4
|
94.52
|
-38.03
|
Net income
1 |
113.3
|
247
|
115.3
|
-373.1
|
90.06
|
-43.94
|
Net margin
|
13.47%
|
14.43%
|
6.75%
|
-30.15%
|
6.74%
|
-2.43%
|
EPS
2 |
0.5188
|
1.131
|
0.4812
|
-1.709
|
0.3525
|
-0.1696
|
Free Cash Flow
1 |
-368.6
|
-241.5
|
-664.5
|
51.11
|
787.7
|
102.3
|
FCF margin
|
-43.82%
|
-14.1%
|
-38.91%
|
4.13%
|
58.95%
|
5.67%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
39.74%
|
306.64%
|
42.31%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
874.67%
|
-
|
Dividend per Share
2 |
0.1100
|
0.2300
|
0.1100
|
-
|
0.1000
|
-
|
Announcement Date
|
3/30/18
|
3/28/19
|
4/26/20
|
4/26/21
|
3/7/22
|
3/29/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
372
|
824
|
1,227
|
1,280
|
176
|
166
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.061
x
|
1.775
x
|
3.056
x
|
9.956
x
|
0.6854
x
|
0.6883
x
|
Free Cash Flow
1 |
-369
|
-241
|
-665
|
51.1
|
788
|
102
|
ROE (net income / shareholders' equity)
|
9.26%
|
18.6%
|
9%
|
-23.1%
|
4.18%
|
-2.95%
|
ROA (Net income/ Total Assets)
|
4.09%
|
7.43%
|
5.01%
|
1.02%
|
2.99%
|
2.88%
|
Assets
1 |
2,767
|
3,327
|
2,302
|
-36,661
|
3,010
|
-1,524
|
Book Value Per Share
2 |
5.480
|
6.540
|
7.380
|
5.530
|
6.400
|
6.280
|
Cash Flow per Share
2 |
1.000
|
1.330
|
2.000
|
2.390
|
2.240
|
1.900
|
Capex
1 |
208
|
341
|
302
|
289
|
62.2
|
114
|
Capex / Sales
|
24.77%
|
19.91%
|
17.7%
|
23.33%
|
4.65%
|
6.34%
|
Announcement Date
|
3/30/18
|
3/28/19
|
4/26/20
|
4/26/21
|
3/7/22
|
3/29/23
|
|
1st Jan change
|
Capi.
|
---|
| -26.25% | 326M | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.26B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|